Tu et al. found that indomethacin can inhibit the proliferation of chronic myeloid leukemia cells and down-regulate Bcl-2 gene expression to induce apoptosis [20]. The gene discussed is BCL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.